From October 1, 2023 to December 31, 2023, the company has repurchased 303,400 shares, representing 0.18% for CNY 3.9 million. With this, the company has completed the repurchase of 724,500 shares, representing 0.42% for CNY 8.97 million under the buyback announced on May 9, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.7 CNY | +1.41% | +6.45% | -5.97% |
1st Jan change | Capi. | |
---|---|---|
-5.97% | 321M | |
+16.80% | 8.43B | |
+15.02% | 6.82B | |
-4.12% | 3.77B | |
-6.75% | 3.74B | |
+4.41% | 1.44B | |
-25.75% | 1.06B | |
+20.28% | 1.04B | |
-11.47% | 890M | |
-16.89% | 812M |
- Stock Market
- Equities
- 603079 Stock
- News Zhejiang Shengda Bio-Pharm Co., Ltd.
- Tranche Update on Zhejiang Shengda Bio-Pharm Co., Ltd.'s Equity Buyback Plan announced on May 9, 2023.